DHEA supplements are becoming quite popular. And for the right reasons: DHEA supplements has the potential for a wide range of health benefits. These potential health benefits include more energy, strong muscles and bones, better mood, balanced hormone levels, healthy immune function, and improved brain and heart health.
Each capsule contains 25 mg of DHEA.
Take one capsule a day or as recommended by a healthcare professional. The usual starting dose of DHEA is 25 mg a day. Then, you can slowly increase it under the supervision of a doctor.*
What is DHEA anyway?
DHEA stands for DEHYDROEPIANDROSTERONE. It is a hormone which is produced mainly by the adrenal glands – two tiny structures sitting on top of your kidneys. DHEA is also produced by the testis, ovaries, skin, and brain. DHEA that comes from the adrenal glands is sulfated DHEA. It is called DHEA-S (DEHYDROEPIANDROSTERONE Sulfate.)
DHEA is produced from cholesterol. There is some concern that too low of cholesterol may decrease your DHEA levels.
DHEA also converts into testosterone and estrogen in both women and men.
Why do DHEA levels go down?
- Age – Your DHEA levels go down as you age. It is called “adrenopause”. By the age of 70–80 years, your level of DHEA may be as low as 10%–20% of your young age.
- severe systemic illness
- anorexia nervosa
- adrenal insufficiency
Symptoms of Low DHEA
Symptoms of low levels of DHEA include:
- Chronic fatigue
- Weak muscles
- Weak bones
- Decreased sense of well-being
- Poor immune function
- Low sex drive
- Erectile dysfunction in men
- Vaginal dryness and pain during sex in women
You should have your DHEA level checked by your healthcare practitioner if you suspect low DHEA level. It can tested in the blood or saliva.
Potential Benefits of DHEA supplements
As mentioned above, most of us end up having low DHEA as we age. But, there is good news. With DHEA supplements we can boost our DHEA levels back into the healthy range. Numerous scientific studies support the following health benefits of DHEA supplements:
May improve muscle mass and prevent fracture
Most people break their bones after they take a fall. One of the major risk factors for falls in the elderly is muscle weakness. Your muscle mass decreases with age at a rate of 6% per decade, beginning around age 45. The risk for a bone fracture goes high as we age: 51% for women and 20% for men after the age of 50 are at risk of having a bone fracture.
Studies show DHEA supplementation may improve your body composition, muscle strength, and physical performance.(1,2,3,4)
DHEA Supplementation may improve bone density
In post-menopausal women, several studies show a beneficial effect of DHEA supplement on the bone density. 2,67,8,9
Positive effects of DHEA supplement on bone density have also been reported in men as well.7,8,10,11
DHEA Supplements may improve depression
Low levels of DHEA have been related to depression. 12,13 DHEA supplementation has been shown to improve depression.15,16,17
DHEA may be good for the cardiovascular health
Animal studies have suggested a beneficial effect of DHEA against atherosclerosis – hardening of the arteries. 18,19,20,21
Indeed, low DHEA predicted ischemic heart disease in a group of men in a 9-year follow-up study.22
Other researchers found an inverse relationship between DHEA levels and atherosclerosis of the common carotid artery. In other words, the lower the DHEA levels, the higher the risk of hardening of the common carotid arteries.23
Low DHEA levels were also associated with more severe coronary atherosclerosis in 206 middle-aged individuals. 24
Scientific studies supports a relationship between heart failure and low DHEA levels. In men, low DHEA has been associated with higher overall and cardiovascular mortality.25 In the same study, an increase of DHEA levels by 100 μg/dL was associated with a reduction of all cause mortality by 36% and cardiovascular mortality by 48%.25
DHEA supplements may improve sexual function in men and women
Low DHEA levels have been related to a higher risk for erectile dysfunction.26, 27,28 Scientific studies show DHEA supplementation may improve erectile function, desire, sexual interest, sexual activity, arousal, and fantasy.29
In one study, intra-vaginal administration of DHEA in women improved sexual arousal, sensation, lubrication, orgasm, and pain during sexual activity.30
In another study intra-vaginal administration of DHEA was effective for reversing vaginal atrophy in post-menopausal women. 31
The risk for breast cancer does not seem to increase with DHEA. 32
Side-effects of DHEA Supplements
Use of DHEA supplement is generally safe.
In women, only minimal adverse effects have been reported such as mild acne, seborrhea, facial hair growth, and ankle swelling. In a study, no adverse effects were observed on endometrium – lining of the uterus – or breast. 32
However, you probably should avoid DHEA supplements if you have – or a history of – breast or endometrial cancer. Men with prostate cancer should avoid DHEA supplements.
Discuss with your healthcare professional before taking DHEA supplement.
Dose of DHEA Supplements
Usual dose of DHEA supplement is 25-50 mg per day. Doses up 100 mg have been used in clinical studies and found to be safe. It is a good idea to start low such as 25 mg dose and then increase slowly.
*These statements have not been evaluated by the Food and Drug Administration. This product in not intended to diagnose, treat, cure or prevent any disease.
1. Morales AJ. Haubrich RH. Hwang JY. Asakura H. Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol. 1998;49:421–432. [PubMed]
4. Kenny AM. Boxer RS. Kleppinger A. Brindisi J. Feinn R. Burleson JA. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc. 2010;58:1707–1714. [PubMed]
5. Weiss EP. Shah K. Fontana L. Lambert CP. Holloszy JO. Villareal DT. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. 2009;89:1459–1467.[PMC free article] [PubMed]
6. von Muhlen D. Laughlin GA. Kritz-Silverstein D. Bergstrom J. Bettencourt R. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: The DAWN trial. Osteoporosis Int. 2008;19:699–707. [PMC free article] [PubMed]
7. Jankowski CM. Gozansky WS. Kittelson JM. Van Pelt RE. Schwartz RS. Kohrt WM. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens. J Clin Endocrinol Metab. 2008;93:4767–4773. [PMC free article] [PubMed]
8. Jankowski CM. Gozansky WS. Schwartz RS. Dahl DJ. Kittelson JM. Scott SM. Van Pelt RE. Kohrt WM. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: A randomized, controlled trial. J Clin Endocrinol Metab. 2006;91:2986–2993. [PubMed]
9. Labrie F. Diamond P. Cusan L. Gomez JL. Belanger A. Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab. 1997;82:3498–3505. [PubMed]
10. Sun Y. Mao M. Sun L. Feng Y. Yang J. Shen P. Treatment of osteoporosis in men using dehydroepiandrosterone sulfate. Chinese Med J. 2002;115:402–404. [PubMed]
11. Nair KS. Rizza RA. O’Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355:1647–1659. [PubMed]
12. Barrett-Connor E. von Muhlen D. Laughlin GA. Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. J Am Geriatr Soc. 1999;47:685–691. [PubMed]
13. Michael A. Jenaway A. Paykel ES. Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry. 2000;48:989–995. [PubMed]
14. Schmidt PJ. Daly RC. Bloch M. Smith MJ. Danaceau MA. St Clair LS. Murphy JH. Haq N. Rubinow DR. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005;62:154–162. [PubMed]
15. Wolkowitz OM. Reus VI. Roberts E. Manfredi F. Chan T. Raum WJ. Ormiston S. Johnson R. Canick J. Brizendine L. Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 1997;41:311–318. [PubMed]
16. Wolkowitz OM. Reus VI. Keebler A, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999;156:646–649. [PubMed]
17. Bloch M. Schmidt PJ. Danaceau MA. Adams LF. Rubinow DR. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry. 1999;45:1533–1541. [PubMed]
18. Hayashi T. Esaki T. Muto E. Kano H. Asai Y. Thakur NK. Sumi D. Jayachandran M. Iguchi A. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: The possible role of nitric oxide. Arterioscler Thromb Vasc Biol. 2000;20:782–792. [PubMed]
19. Gordon GB. Bush DE. Weisman HF Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. J Clin Invest. 1988;82:712–720. [PMC free article] [PubMed]
20. Wang L. Hao Q. Wang YD. Wang WJ. Li DJ. Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells. Atherosclerosis. 2011;214:47–57. [PubMed]
21. Eich DM. Nestler JE. Johnson DE. Dworkin GH. Ko D. Wechsler AS. Hess ML. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation. 1993;87:261–269. [PubMed]
22. Feldman HA. Johannes CB. Araujo AB. Mohr BA. Longcope C. McKinlay JB. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: Prospective results from the Massachusetts Male Aging Study. Am J Epidemiol. 2001;153:79–89. [PubMed]
23. Yoshida S. Aihara K. Azuma H. Uemoto R. Sumitomo-Ueda Y. Yagi S. Ikeda Y. Iwase T. Nishio S. Kawano H. Miki J. Yamada H. Hirata Y. Akaike M. Sata M. Matsumoto T. Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function. Atherosclerosis. 2010;212:310–315. [PubMed]
24. Herrington DM. Dehydroepiandrosterone and coronary atherosclerosis. Ann NY Acad Sci. 1995;774:271–280. [PubMed]
25. Barrett-Connor E. Khaw KT. Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986;315:1519–1524. [PubMed
26. Basar MM. Aydin G. Mert HC. Keles I. Caglayan O. Orkun S. Batislam E. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology. 2005;66:597–601. [PubMed]
27. Alexopoulou O. Jamart J. Maiter D. Hermans MP. De Hertogh R. De Nayer P. Buysschaert M. Erectile dysfunction and lower androgenicity in type 1 diabetic patients. Diabetes Metab. 2001;27:329–336. [PubMed]
28. Feldman HA. Goldstein I. Hatzichristou DG. Krane RJ. McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.[PubMed]
29. Reiter WJ. Pycha A. Schatzl G. Pokorny A. Gruber DM. Huber JC. Marberger M. Dehydroepiandrosterone in the treatment of erectile dysfunction: A prospective, double-blind, randomized, placebo-controlled study. Urology. 1999;53:590–594. [PubMed]
30. Labrie F. Archer D. Bouchard C. Fortier M. Cusan L. Gomez JL. Girard G. Baron M. Ayotte N. Moreau M. Dubé R. Côté I. Labrie C. Lavoie L. Berger L. Gilbert L. Martel C. Balser J. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause. 2009;16:923–931. [PubMed
31. Labrie F. Archer D. Bouchard C. Fortier M. Cusan L. Gomez JL. Girard G. Baron M. Ayotte N. Moreau M. Dubé R. Côté I. Labrie C. Lavoie L. Berger L. Gilbert L. Martel C. Balser J. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause. 2009;16:907–922. [PubMed]
32. Labrie F. Luu-The V. Bélanger A. Lin SX. Simard J. Pelletier G. Labrie C. Is dehydroepiandrosterone a hormone? J Endocrinol. 2005;187:169–196. [PubMed]